Exact Mass: 463.0783

Exact Mass Matches: 463.0783

Found 31 metabolites which its exact mass value is equals to given mass value 463.0783, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Adenylsuccinic acid

(2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.074)


Adenylsuccinic acid, also known as adenylosuccinate, succinyladenosine or aspartyl adenylate, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenylsuccinic acid is found in all living organisms, ranging from bacteria to plants to animals. Adenylsuccinic acid is an important intermediate in the de novo purine biosynthesis pathway. Specifically, adenylsuccinic acid is an intermediate in the interconversion of purine nucleotides inosine monophosphate (IMP) and adenosine monophosphate (AMP). The enzyme adenylosuccinate synthase carries out the reaction by the addition of aspartate to IMP. This reaction requires the input of energy from a phosphoanhydride bond in the form of guanosine triphosphate (GTP). Adenylsuccinic acid is a substrate least one other important metabolic reaction in purine biosynthesis. In particular, adenylsuccinic acid can be converted into fumaric acid through its interaction with the enzyme known as adenylosuccinate lyase (or adenylosuccinase). Adenylosuccinate lyase deficiency, is a rare autosomal recessive metabolic disorder characterized by the appearance of succinylaminoimidazolecarboxamide riboside (SAICA riboside) and adenylsuccinic acid in cerebrospinal fluid and urine (PMID: 8412002). Adenylosuccinate lyase deficiency presents with varying degrees of psychomotor retardation, autism, muscle wasting, and epilepsy. The exact cause of the symptoms is unknown, but possibilities include not enough purine nucleotide synthesis for cell replication, malfunctioning of the purine nucleotide cycle, and a buildup of substrates to toxic levels. Adenylsuccinic acid is a substrate of the enzyme adenylosuccinase [EC 4.3.2.2] in purine metabolism pathway. The accumulation of adenylsuccinic acid in body fluids occurs due to a deficiency of adenylosuccinase. (KEGG; PMID 8412002) [HMDB] D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids KEIO_ID A037; [MS2] KO008839 KEIO_ID A037; [MS3] KO008840 KEIO_ID A037

   

L 735821

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

C25H19Cl2N3O2 (463.0854)


D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators

   

Adenylosuccinic acid

2-[(9-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-9H-purin-6-yl)amino]butanedioic acid

C14H18N5O11P (463.074)


   

Adenylsuccinic acid

Adenylosuccinic acid

C14H18N5O11P (463.074)


   

N-(5-chloro-2-methylphenyl)-4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

N-(5-chloro-2-methylphenyl)-4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

C25H19Cl2N3O2 (463.0854)


   
   

2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylanilino]ethyl acetate

2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylanilino]ethyl acetate

C20H19Cl2N5O4 (463.0814)


   

[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0787)


   

[2-[(3-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(3-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0787)


   

[2-[(4-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

[2-[(4-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate

C26H16ClF2NO3 (463.0787)


   

N-(4-chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

N-(4-chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide

C25H19Cl2N3O2 (463.0854)


   

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine

C27H18BrN3 (463.0684)


   

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine

C27H18BrN3 (463.0684)


   

2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranuronosyloxy)-5,7-dihydroxy-1-benzopyrylium

2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranuronosyloxy)-5,7-dihydroxy-1-benzopyrylium

C21H19O12 (463.0876)


   

Aspartyl adenylate

Aspartyl adenylate

C14H18N5O11P (463.074)


D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids

   

quercetin-3-glucoside

quercetin-3-glucoside

C21H19O12- (463.0876)


   
   

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate

2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate

C21H19O12- (463.0876)


   

Quercetin 4-O-beta-D-glucoside

Quercetin 4-O-beta-D-glucoside

C21H19O12- (463.0876)


   

delfinidin-3-O-glucoside

delfinidin-3-O-glucoside

C21H19O12- (463.0876)


   

9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

C25H22BrNO3 (463.0783)


   

N-(1,3-benzodioxol-5-yl)-2-[[4-(4-methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]acetamide

N-(1,3-benzodioxol-5-yl)-2-[[4-(4-methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]acetamide

C21H16F3N3O4S (463.0814)


   

Myricetin 3-O-alpha-L-rhamnoside

Myricetin 3-O-alpha-L-rhamnoside

C21H19O12- (463.0876)


   

3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxychromenylium-2-yl)phenoxy]oxane-2-carboxylic acid

3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxychromenylium-2-yl)phenoxy]oxane-2-carboxylic acid

C21H19O12+ (463.0876)


   

6-[2-(3,4-Dihydroxyphenyl)-3,5-dihydroxychromenylium-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[2-(3,4-Dihydroxyphenyl)-3,5-dihydroxychromenylium-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C21H19O12+ (463.0876)


   

delphinidin 3-O-beta-D-galactoside(1-)

delphinidin 3-O-beta-D-galactoside(1-)

C21H19O12- (463.0876)


   

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide

C25H19Cl2N3O2 (463.0854)


D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators

   

N(6)-(1,2-dicarboxyethyl)-AMP

N(6)-(1,2-dicarboxyethyl)-AMP

C14H18N5O11P (463.074)


The N(6)-(1,2-dicarboxyethyl) derivative of adenosine 5-monophosphate.

   

myricitrin(1-)

myricitrin(1-)

C21H19O12 (463.0876)


A flavonoid oxoanion that is the conjugate base of myricitrin arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.

   

quercetin 3-O-beta-D-glucopyranoside(1-)

quercetin 3-O-beta-D-glucopyranoside(1-)

C21H19O12 (463.0876)


A flavonoid oxoanion resulting from the deprotonation of the hydroxy group at position 7 of the flavone moiety of quercetin. The major species at pH 7.3.

   

(2r)-2-({9-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]purin-6-yl}amino)butanedioic acid

(2r)-2-({9-[(2s,3s,4r,5r)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.074)